Search

A biannual magazine of the City of Cambridge that features City programs, initiatives, and services for Cambridge residents.

A biannual magazine of the City of Cambridge that features City programs, initiatives, and services for Cambridge residents.

A biannual magazine of the City of Cambridge that features City programs, initiatives, and services for Cambridge residents.

Cartoons and Discussion Series

Join the Cambridge Commission for Persons with Disabilities (CCPD) to march in Cambridge Arts’ River Festival Parade and celebrate the upcoming 35th anniversary of the American Disabilities Act (ADA). 

This report examines the feasibility of the City of Cambridge implementing a municipal fiber-to-the-premises (FTTP) service and finds that for the City to construct an FTTP network and establish a financially sustainable business—meaning one that covers its costs and generates a reasonable rate of return over a long period—a significant public contribution would be required. In a base-case scenario that applies conservative construction cost assumptions and reasonable revenue projections, the network could require an upfront public capital contribution of $150 million.

School's almost out, so let's celebrate! Join us for pizza and crafts and relax before exams. Bring your friends. And of course - it's free! Presented by the CPL Teen Advisory Board.

The City of Cambridge is one of only 22 cities in the United States to earn the highest credit rating possible from Moody’s Investors Service, S&P Global Ratings, and Fitch Ratings. The City has achieved this distinction of earning AAA ratings from each of the nation’s three major credit rating agencies every year since 1999.

The Cambridge Police Department Traffic Unit sought public assistance to identify the individual pictured with regard to an on-going investigation into a hit & run crash on Vassar St. that caused serious injuries to a 9-year-old. This individual has since been identified.

On Tuesday, April 13, federal health agencies recommended an immediate pause in the use of the Johnson & Johnson COVID-19 vaccine following reports of six people who developed a rare and severe type of blood clot within two weeks of receiving the vaccine.